Trial record 1 of 1 for:    NCT00942877
Previous Study | Return to List | Next Study

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00942877
Recruitment Status : Active, not recruiting
First Posted : July 21, 2009
Last Update Posted : May 22, 2018
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : July 31, 2017
  Estimated Study Completion Date : July 31, 2019
Publications automatically indexed to this study by Identifier (NCT Number):